Coronado Biosciences Pulls in $25.8 Million

7/6/11

New York City-based Coronado Biosciences has raised $25.8 million, according to a regulatory filing. The company is developing immunotherapy approaches to treating acute myeloid leukemia, inflammatory bowel disease, multiple sclerosis, and other autoimmune diseases. It previously raised $21.6 million in November 2010.

By posting a comment, you agree to our terms and conditions.